older man looking into the camera

older woman looking into the camera

COMBINING
TO CURE^®

People and science are a beautiful combination.

Arcus is at the forefront of designing combination therapies, with best-in-class potential, in our relentless pursuit of cures for cancer.

Featured

Arcus News: Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer

Arcus News: Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response

PORTRAITS OF CANCER: People are sharing their stories in ways they’ve never been able to before.

We are combining

DISCOVERY CAPABILITIES

Producing differentiated small molecules and antibodies designed to optimize combinability

ACCELERATED DEVELOPMENT

Guided by specific biologic mechanisms of cancer, to advance combination therapies from Phase 1 studies through commercialization

PARTNERSHIP WITH THE CANCER COMMUNITY

To facilitate participation in our global clinical trials and bring new medicines to patients faster

Joining forces to defeat cancer.
This is COMBINING TO CURE

Explore More